Literature DB >> 8709087

A fatal trip with ecstasy: a case of 3,4-methylenedioxymethamphetamine/3,4- methylenedioxyamphetamine toxicity.

J R Coore1.   

Abstract

Since the late 1980s there have been a number of reports about the complications associated with using the designer drug 3,4-methylenedioxymethamphetamine (MDMA) or 'ecstasy'. Although this drug has been widely abused in the past, the potentially fatal complications have arisen recently mainly due to the circumstances of its use at all-night dance sessions or 'raves'. A combination of direct toxicity and strenuous physical exertion can lead to hyperthermia and its attendant complications. The following case illustrates some of the possible consequences following ingestion of 'ecstasy', and reiterates the importance of prompt recognition and treatment in preventing the development of irreversible sequelae.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8709087      PMCID: PMC1295645          DOI: 10.1177/014107689608900115

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   18.000


  6 in total

1.  Another death from Ecstacy.

Authors:  N T Campkin; U M Davies
Journal:  J R Soc Med       Date:  1992-01       Impact factor: 5.344

Review 2.  The serotonin syndrome.

Authors:  H Sternbach
Journal:  Am J Psychiatry       Date:  1991-06       Impact factor: 18.112

Review 3.  Field and clinical observations of exertional heat stroke patients.

Authors:  Y Shapiro; D S Seidman
Journal:  Med Sci Sports Exerc       Date:  1990-02       Impact factor: 5.411

4.  Ecstasy, the serotonin syndrome, and neuroleptic malignant syndrome--a possible link?

Authors:  D Ames; W C Wirshing
Journal:  JAMA       Date:  1993-02-17       Impact factor: 56.272

Review 5.  Exertional heat stroke induced by amphetamine analogues. Does dantrolene have a place?

Authors:  J D Watson; C Ferguson; C J Hinds; R Skinner; J H Coakley
Journal:  Anaesthesia       Date:  1993-12       Impact factor: 6.955

6.  Toxicity and deaths from 3,4-methylenedioxymethamphetamine ("ecstasy")

Authors:  J A Henry; K J Jeffreys; S Dawling
Journal:  Lancet       Date:  1992-08-15       Impact factor: 79.321

  6 in total
  6 in total

1.  Raves: a review of the culture, the drugs and the prevention of harm.

Authors:  E Weir
Journal:  CMAJ       Date:  2000-06-27       Impact factor: 8.262

Review 2.  The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs.

Authors:  H Kalant
Journal:  CMAJ       Date:  2001-10-02       Impact factor: 8.262

3.  "Ecstasy" associated deaths: what is a fatal concentration ? Analysis of a case series.

Authors:  C M Milroy
Journal:  Forensic Sci Med Pathol       Date:  2011-01-25       Impact factor: 2.007

Review 4.  The role of the sympathetic nervous system and uncoupling proteins in the thermogenesis induced by 3,4-methylenedioxymethamphetamine.

Authors:  Edward M Mills; Daniel E Rusyniak; Jon E Sprague
Journal:  J Mol Med (Berl)       Date:  2004-11-10       Impact factor: 4.599

5.  Attenuation of 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy)-induced rhabdomyolysis with alpha1- plus beta3-adrenoreceptor antagonists.

Authors:  Jon E Sprague; Robert E Brutcher; Edward M Mills; David Caden; Daniel E Rusyniak
Journal:  Br J Pharmacol       Date:  2004-05-24       Impact factor: 8.739

Review 6.  3,4-methylenedioxymethamphetamine (MDMA): a review.

Authors:  G O'Leary; J Nargiso; R D Weiss
Journal:  Curr Psychiatry Rep       Date:  2001-12       Impact factor: 8.081

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.